# Indicated Prevention of Psychotic Disorders With Low-dose Lithium

> **NCT00202306** · PHASE4 · COMPLETED · sponsor: **Melbourne Health** · enrollment: 30 (estimated)

## Conditions studied

- Schizophrenia
- Bipolar Disorder
- Psychotic Disorders

## Interventions

- **DRUG:** lithium carbonate

## Key facts

- **NCT ID:** NCT00202306
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202306, "Indicated Prevention of Psychotic Disorders With Low-dose Lithium". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00202306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*